In a filing, Ironwood Pharmaceuticals Inc revealed its Director Duane Jon R acquired Company’s shares for reported $60204.0 on Mar 06 ’24. In the deal valued at $8.70 per share,6,920 shares were bought. As a result of this transaction, Duane Jon R now holds 121,028 shares worth roughly $0.97 million.
Then, Emany Sravan Kumar bought 10,684 shares, generating $100,216 in total proceeds. Upon buying the shares at $9.38, the SVP, Chief Financial Officer now owns 301,733 shares.
Before that, MCCOURT Thomas A sold 177,164 shares. Ironwood Pharmaceuticals Inc shares valued at $2,699,979 were divested by the Chief Executive Officer at a price of $15.24 per share. As a result of the transaction, MCCOURT Thomas A now holds 832,774 shares, worth roughly $6.68 million.
Craig Hallum initiated its Ironwood Pharmaceuticals Inc [IRWD] rating to a Buy in a research note published on January 17, 2024; the price target was $21. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in mid December with a ‘”an Overweight”‘ rating. Jefferies began covering IRWD with “Buy” recommendation on November 09, 2023. JMP Securities started covering the stock on September 28, 2023. It rated IRWD as “a Mkt outperform”.
Price Performance Review of IRWD
On Monday, Ironwood Pharmaceuticals Inc [NASDAQ:IRWD] saw its stock fall -0.50% to $8.02. Over the last five days, the stock has lost -6.85%. Ironwood Pharmaceuticals Inc shares have fallen nearly -29.90% since the year began. Nevertheless, the stocks have fallen -23.98% over the past one year. While a 52-week high of $15.70 was reached on 02/14/24, a 52-week low of $7.98 was recorded on 04/08/24. SMA at 50 days reached $11.50, while 200 days put it at $10.52. A total of 2.31 million shares were traded, compared to the trading of 2.55 million shares in the previous session.
Levels Of Support And Resistance For IRWD Stock
The 24-hour chart illustrates a support level at 7.82, which if violated will result in even more drops to 7.62. On the upside, there is a resistance level at 8.19. A further resistance level may holdings at 8.36. The Relative Strength Index (RSI) on the 14-day chart is 29.41, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.42, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.03%. Stochastics %K at 9.76% indicates the stock is a buying.
How much short interest is there in Ironwood Pharmaceuticals Inc?
A steep rise in short interest was recorded in Ironwood Pharmaceuticals Inc stocks on Mar 15, 2024, growing by 3.17 million shares to a total of 18.77 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 15.6 million shares. There was a rise of 16.89%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 19.54% of the overall stock float, the days-to-cover ratio (short ratio) rose to 2.46.
The most recent change occurred on September 02, 2022 when CapitalOne began covering the stock and recommended ‘”an Overweight”‘ rating along with a $15 price target.
